当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Shreya Shetty, Ramesh Kohad, Ramreddy Yeltiwar and Karunakar Shetty
Background: The search for an agent that would predictably and permanently occlude the tubules, and blend with them led to the discovery of HYDROXYAPATITE (HAP). The present double blinded randomsed controlled clinical trial aimed to compare the desensitizing effects of two forms of HAP with 2 other popular agents, potassium nitrate and potassium nitrate with sodium monofluorophosphate. Methods: Clinical study: 716 hypersensitive teeth in 50 patients with hypersensitive symptoms, confirmed by visual analogue scale (VAS) and verbal rating scale (VRS), were randomly divided into 4 groups (A,B,C and D) treated with HAP dry sol gel and liquid precipitate form, potassium nitrate and sodium monofluorophosphate respectively. The responses were evaluated at 0, 1 day, 1, 2, 4 and 8 weeks respectively for all groups and later statistically analysed. Results: HAP treated teeth showed statistically significant reduction in hypersensitive symptoms (p<0.001) requiring fewer applications compared to other groups at the end of 1st day, 2 and 8 weeks respectively. At the end of 8 weeks, all 4 groups showed significant change from baseline scores (p<0.001). Conclusion: HAP showed definite potential as an effective permanent desensitizer when compared to potassium nitrate and sodium monofluorophosphate when used as an in-office procedure. However, its efficacy when used as part of dentifrice like the other 2 agents needs further research.